Janus Henderson Group PLC Buys 54,263 Shares of Colgate-Palmolive (CL)

Janus Henderson Group PLC boosted its stake in shares of Colgate-Palmolive (NYSE:CL) by 7.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 771,368 shares of the company’s stock after purchasing an additional 54,263 shares during the period. Janus Henderson Group PLC owned 0.09% of Colgate-Palmolive worth $56,182,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Pacer Advisors Inc. raised its stake in Colgate-Palmolive by 8.4% in the second quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock valued at $1,499,000 after buying an additional 1,566 shares during the period. Fiduciary Trust Co. raised its stake in Colgate-Palmolive by 1.6% in the second quarter. Fiduciary Trust Co. now owns 170,818 shares of the company’s stock valued at $12,663,000 after buying an additional 2,758 shares during the period. The Manufacturers Life Insurance Company raised its stake in Colgate-Palmolive by 10.3% in the second quarter. The Manufacturers Life Insurance Company now owns 1,131,987 shares of the company’s stock valued at $83,914,000 after buying an additional 105,878 shares during the period. Pensionfund DSM Netherlands bought a new stake in Colgate-Palmolive in the third quarter valued at approximately $4,225,000. Finally, Pacad Investment Ltd. bought a new stake in Colgate-Palmolive in the second quarter valued at approximately $549,000. 72.86% of the stock is owned by hedge funds and other institutional investors.

In other Colgate-Palmolive news, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $73.07, for a total transaction of $730,700.00. Following the transaction, the insider now owns 60,528 shares in the company, valued at approximately $4,422,780.96. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Jennifer Daniels sold 902 shares of the firm’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total value of $68,389.64. Following the transaction, the insider now owns 37,788 shares in the company, valued at approximately $2,865,086.16. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 181,950 shares of company stock worth $13,237,385. Corporate insiders own 1.02% of the company’s stock.

Colgate-Palmolive (CL) opened at $76.63 on Friday. Colgate-Palmolive has a 52 week low of $63.43 and a 52 week high of $77.29. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The company has a market capitalization of $67,333.11, a price-to-earnings ratio of 29.59, a price-to-earnings-growth ratio of 3.20 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same quarter last year, the company earned $0.73 EPS. The company’s revenue was up 2.8% on a year-over-year basis. equities analysts forecast that Colgate-Palmolive will post 2.87 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. The ex-dividend date is Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a yield of 2.09%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.

Several analysts have issued reports on the company. Zacks Investment Research lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 17th. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Macquarie upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price on the stock in a research note on Tuesday, December 19th. Deutsche Bank assumed coverage on Colgate-Palmolive in a research note on Wednesday, December 13th. They set a “hold” rating and a $75.00 target price on the stock. Finally, SunTrust Banks upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and increased their target price for the stock from $65.00 to $85.00 in a research note on Wednesday, October 11th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $76.45.

TRADEMARK VIOLATION NOTICE: “Janus Henderson Group PLC Buys 54,263 Shares of Colgate-Palmolive (CL)” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://ledgergazette.com/2018/01/19/janus-henderson-group-plc-buys-54263-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply